Pathfinder Therapeutics Lands $5 Million Series A Round – Financing Led by Hatteras Venture Partners Helps Launch the First System for Surgical Guidance in the Abdomen
Published: Oct 30, 2008
NASHVILLE, Tenn.--(BUSINESS WIRE)--Pathfinder Therapeutics, Inc. (PTI), a medical device company focused on the development of “surgical GPS” systems for the abdomen, announced that it has closed on a $5.2 million Series A financing round led by Hatteras Venture Partners of Research Triangle Park, NC. Other investors included Florida Gulfshore Capital, Clayton & Associates, Nashville Capital Network, Lumira, and Vanderbilt University. Concurrent with the financing, Clay Thorp and Bob Morff, PhD, from Hatteras Venture Partners and Richard Molloy from Florida Gulfshore Capital have joined the Board of Pathfinder, and Bob will serve as interim CEO.